Radiation Therapy Oncology Group 9910: Phase 3 Trial to Evaluate the Duration of Neoadjuvant (NEO) Total Androgen Suppression (TAS) and Radiation Therapy (RT) in Intermediate-Risk Prostate Cancer (PCa)
Pisansky, T.M, Hunt, D, Gomella, L.G, Amin, M.B, Balogh, A.G, Chinn, D.M, Seider, M, Duclos, M, Rosenthal, S.A, Sandler, H.M
Published in International journal of radiation oncology, biology, physics (01.10.2013)
Published in International journal of radiation oncology, biology, physics (01.10.2013)
Get full text
Journal Article